about
Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and TatReduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy.Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavirHigh correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.Polypharmacy in the HIV-infected older adult population.Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study.Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy.Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV ModelDetermination of the underlying cause of death in three multicenter international HIV clinical trials.Lack of an Effect of Ritonavir Alone and Lopinavir-Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers.Use of the exercise treadmill test for the assessment of cardiac risk markers in adults infected with HIV.High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa.Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study
P2860
Q28080948-1030D709-67CC-44E3-A8AE-EDA1654247E7Q30481446-1BF43B76-B132-4D76-8E06-60900F22267BQ33625135-551467E4-AEC0-4DAC-AEF2-51827572E167Q33764308-7913791A-7005-49A0-80CA-60B4F7137D59Q34037407-1BE8AE02-8EF7-4697-9555-815B6727D9D8Q34195066-9F63D39D-34DA-4D69-98DD-21A0CD2C7CD9Q35030752-DF1A8AC2-5B47-4974-AB86-6E3695D6BC4BQ35104013-589227AB-086D-4347-BF4B-F2D529BC138AQ35751830-9E6602D3-DADC-4E65-A50D-367E3D4D8F38Q36739701-98ACF313-1AD5-4E7D-AB42-19C4C8C3C44EQ40073748-761BE8FB-DCE5-4AC7-A24F-897B8B1D09F9Q43743906-C8BEB715-3FD4-4975-A516-8EF3C847546EQ46494765-575A8EFA-302C-4A59-96C3-EA0D29DA584FQ57300568-DACB7816-DAC2-452C-9B08-395778D0CA4E
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cardiovascular disease in HIV-positive patients.
@en
Cardiovascular disease in HIV-positive patients.
@nl
type
label
Cardiovascular disease in HIV-positive patients.
@en
Cardiovascular disease in HIV-positive patients.
@nl
prefLabel
Cardiovascular disease in HIV-positive patients.
@en
Cardiovascular disease in HIV-positive patients.
@nl
P1433
P1476
Cardiovascular disease in HIV-positive patients.
@en
P2093
Daniel S Kamin
Steven K Grinspoon
P304
P356
10.1097/01.AIDS.0000166087.08822.BC
P407
P577
2005-04-01T00:00:00Z